Clinical studies recruiting near Guangzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Nanfang Hospital of Southern Medical University · Pfizer · NCT05020236 Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
Phase 2 · Sun Yat-sen University Cancer Center · Sun Yat-sen University · NCT05011487 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Guangzhou Red Cross Hospital · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Phase 1 · The Second Affiliated Hospital of Guangzhou Medical Universi · Second Affiliated Hospital of Guangzhou Medical University · NCT04952272 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · The First Affiliated Hospital of Guangzhou Medical Universit · Eli Lilly and Company · NCT07218380 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-56002, Guangzhou, Guangdong province · Colorado Prevention Center · NCT06024746 ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Phase 1/Phase 2 · Sun Yat-sen University Cancer Center · Sun Yat-sen University · NCT07012954 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 1560002 · Sanofi · NCT06867094 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · Guangdong Provincial People's Hospital · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The First Affiliated Hospital of Guangzhou Medical Universit · Pfizer · NCT07028853 Multifaceted Comparison of Ultrasound-guided Ablation and Laparoscopic Adrenalectomy for Aldosterone-producing Adenoma
Phase N/A · The Third Affiliated Hospital of Sun Yat-sen University · Third Affiliated Hospital, Sun Yat-Sen University · NCT05991856 Electro-Acupuncture in Lung cancER : EALER Study
NA · Guangdong Provincial Hospital of Chinese Medicine · Guangzhou University of Traditional Chinese Medicine · NCT07337096 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Sun Yat-sen University Cancer Center ( Site 2028) · Merck Sharp & Dohme LLC · NCT06136559 IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 · Cancer Center, Sun Yat-sen University · Sun Yat-sen University · NCT05941741 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Sun Yat-sen University Cancer Center · Bristol-Myers Squibb · NCT07106762 Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
Phase 3 · WangHanYu · Sun Yat-sen University · NCT04136886 Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NA · Zhongshan Ophthalmic Center, Sun Yat-sen University · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07126470 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Southern Medical University Dermatology Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in
Phase 4 · Wei Wang · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06520397 Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Phase 2 · Sun Yat-sen University Cancer Center · Sun Yat-sen University · NCT07389629 Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI
NA · Nanfang Hospital, Southern Medical University · Nanfang Hospital, Southern Medical University · NCT05545605 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Nanfang Hospital of Southern Medical University · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0175 · Bristol-Myers Squibb · NCT06929273 Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Phase 2 · Zhenhai Lu · Zhen-Hai Lu · NCT05228431 Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Phase 2 · Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University · Tongji Hospital · NCT06289062 Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Phase 2/Phase 3 · Sun Yat-sen University Cancer Center · Sun Yat-sen University · NCT06280495 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Guangzhou First People's Hospital The First People's Hospita · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169

Look up another city

Look up another condition